Both in Pharmaceuticals
Jade Biosciences vs Corvus Pharmaceuticals
Over the past year JBIO returned +42.1% and CRVS returned +33.5%; their daily moves had a correlation of 0.29.
JBIO +42.1% CRVS +33.5%Growth of $1, one year, split-adjusted
| Metric | JBIO | CRVS |
|---|---|---|
| Price | $14.48 | $10.49 |
| Market cap | $920.9M | $882.4M |
| Today | −1.76% | −0.47% |
| 1 month | +2.1% | −10.8% |
| 6 months | −35.1% | −27.3% |
| Year to date | −6.2% | +36.2% |
| 1 year | +42.1% | +33.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $461.2M | $215.2M |
| Dividend yield | — | — |
| Volatility (60d) | 51.9% | 51.4% |
| Short % of float | 20.7% | 25.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).